Clinical pathology

Stago to Host "Heparin-Induced Thrombocytopenia (HIT): Practical Aspects of Clinical and Laboratory Diagnosis" Virtual Event, February 22nd, 2023

Retrieved on: 
Thursday, February 9, 2023
Clinical pathology, Science, Thrombosis, HIT, Hemostasis, Labroots, Incidence, Heparin, Dentistry

PARSIPPANY, N.J., Feb. 9, 2023 /PRNewswire-PRWeb/ -- Stago to host their "Heparin-Induced Thrombocytopenia (HIT): Practical Aspects of Clinical and Laboratory Diagnosis" webinar on February 22nd, 2023, available any time after 1 pm Eastern Daylight time on the Labroots platform.

Key Points: 
  • Don't miss an opportunity to join Stago, an industry leader in the science of hemostasis and thrombosis, for a new educational webinar
    PARSIPPANY, N.J., Feb. 9, 2023 /PRNewswire-PRWeb/ -- Stago to host their "Heparin-Induced Thrombocytopenia (HIT): Practical Aspects of Clinical and Laboratory Diagnosis" webinar on February 22nd, 2023, available any time after 1 pm Eastern Daylight time on the Labroots platform.
  • At Stago's Virtual Event , expect to learn about Heparin-Induced Thrombocytopenia (HIT), a life-threatening complication following heparin exposure.
  • The event will dive into the pathogenesis, incidence, clinical and laboratory diagnosis, as well as management of HIT.
  • Join this Virtual Event to:
    To register for the event, and view the agenda, click here .

Uppsala University Hospital Selects Proscia to Deliver Full-Scale Digital Pathology Adoption

Retrieved on: 
Thursday, February 3, 2022
Oncology, Data Management, Health, Technology, Hospitals, Software, General Health, Diagnosis, CEO, Patient, Pathology, Workflow, Health, Ecosystem, Clinical pathology, AI, Technology, Adoption, Teaching hospital, Research, Laboratory, Cancer, American Radio Relay League, Marie Cassidy, Medical laboratory, Uppsala University Hospital, Solution, Software, Medical imaging

Proscia , the leader in digital and computational pathology solutions, and Uppsala University Hospital, Swedens oldest university hospital, today announced a multi-year agreement to fully digitize the regions pathology workflows.

Key Points: 
  • Proscia , the leader in digital and computational pathology solutions, and Uppsala University Hospital, Swedens oldest university hospital, today announced a multi-year agreement to fully digitize the regions pathology workflows.
  • The widespread adoption of digital pathology is enabling laboratories to push past the limitations of traditional pathology practices.
  • Proscias Concentriq will equip the clinical pathology lab at University Hospital with streamlined and intuitive workflows that ensure secure, remote access to cases and images.
  • Uppsala University Hospital is propelled by its vision to become the leading university hospital creating the most value for its patients, said professor emerita Irina Alafuzoff, Section Manager of Clinical Pathology, part of the laboratory medicine division at Uppsala University Hospital.

Arkstone Medical Solutions Announces the Appointment of New Director of Molecular Informatics

Retrieved on: 
Tuesday, November 9, 2021
Intelligence, Catholic higher education, Molecular biology, Medicine, Infection, Medical director, Faculty, Clinical pathology, Harvard Medical School, Machine learning, 551st United States Air Force Hospital, Textbook, Biology, BOCA, Hospital, Business administration, Antimicrobial stewardship, Molecular Informatics, Federico Villarreal National University, UHG, Nursing, National university, Pharmaceutical industry

BOCA RATON, Fla., Nov. 9, 2021 /PRNewswire/ -- Arkstone Medical Solutions, the leading provider of proactive antimicrobial stewardship, is pleased to announce the appointment of Dr. Juan Carlos Gmez de la Torre Pretell as their new Director of Molecular Informatics.

Key Points: 
  • BOCA RATON, Fla., Nov. 9, 2021 /PRNewswire/ -- Arkstone Medical Solutions, the leading provider of proactive antimicrobial stewardship, is pleased to announce the appointment of Dr. Juan Carlos Gmez de la Torre Pretell as their new Director of Molecular Informatics.
  • In 2004 he founded the Peruvian Institute of Molecular Biology (IPBM) while continuing his activities in the Roe Clinical Laboratory as head of Molecular Biology and Medical Director.
  • Dr. Gmez is also currently the medical director of Laboratorios Roe, UHG LATAM's main reference laboratory.
  • About Arkstone Medical Solutions: Arkstone is committed to stemming the global spread of antimicrobial resistance and the misuse of antibiotics by marrying advanced artificial intelligence with a deep understanding of infectious disease.

Cabaletta Bio Expands Executive Leadership Team with Appointments of Samik Basu, M.D. to Chief Scientific Officer and Heather Harte-Hall, MSc. to Chief Compliance Officer

Retrieved on: 
Tuesday, November 9, 2021
Industry, Autoimmunity, Clinical trial, Security (finance), National, Regenerative medicine, Growth, CSO, Annual report, University, Laboratory, Business administration, Pfizer, Risk, Safety, Form 10-K, Clinical and Translational Science, Culture, Leadership, Temple University, MPV, Technology, Research, Risk management, U.S. Securities and Exchange Commission, GLOBE, SCCE, Saint Leo University, Albert Einstein College of Medicine, MuSK protein, Patient, FDA, Compliance, Private Securities Litigation Reform Act, Health, Clinical pathology, Society, Pembrolizumab, Ablation, Capella University, LLC, Pemphigus vulgaris, Translational medicine, Merck & Co., Public health, ARM, Pemphigus, CCO, Degenerative disease, Quality, Pharmaceutical industry, Vaccine

to Chief Scientific Officer (CSO) and Heather Harte-Hall to Chief Compliance Officer (CCO).

Key Points: 
  • to Chief Scientific Officer (CSO) and Heather Harte-Hall to Chief Compliance Officer (CCO).
  • Samik and Heather are both highly respected and accomplished leaders at Cabaletta and we are thrilled to announce their well-deserved promotions to these new roles.
  • Dr. Basu joined Cabaletta in December 2019 and was most recently Vice President of Preclinical Research and Translational Medicine before assuming his new role as Chief Scientific Officer.
  • Ms. Harte-Hall joined Cabaletta in March 2019 and was most recently Vice President of Quality and Compliance before assuming her new role as Chief Compliance Officer.

Brickell Biotech to Host Key Opinion Leader Webinar on DYRK1A and its Role in Autoimmunity

Retrieved on: 
Friday, September 17, 2021
Precision medicine, Massachusetts, Autoimmunity, Hyperhidrosis, Intellectual property, Inflammation, Virginia Mason Medical Center, Humanitarian use licenses, KOL, Benaroya Research Institute, Investor, Massachusetts Institute of Technology, DYRK1A, Patient, Down syndrome, Nasdaq, Technology, Clinical trial, U.S. Securities and Exchange Commission, Private Securities Litigation Reform Act, Harvard Medical School, Assistant, Hospital, Therapy, Transfusion medicine, Rheumatoid arthritis, Washington University in St. Louis, Clinical pathology, COVID-19, Dual, Degenerative disease, EDT, GLOBE, Massachusetts General Hospital, Atopic dermatitis, SEC, Research, Time, BBI, Leadership, Pharmaceutical industry

Brickells management team will also provide a brief update on the Companys investigational DYRK1A inhibitor platform.

Key Points: 
  • Brickells management team will also provide a brief update on the Companys investigational DYRK1A inhibitor platform.
  • The webinar will be accessible via a webcast posted on the Events and Presentation page in the Investors section of Brickells website at https://ir.brickellbio.com/events-presentations .
  • For those unable to watch this broadcasted event live, a replay will be available on the Brickell website following the event.
  • The forward-looking statements represent the estimates of Brickell as of the date hereof only, and Brickell specifically disclaims any duty or obligation to update forward-looking statements.

The Worldwide Contract Research Organization Services Industry is Expected to Reach $86.5 Billion by 2026

Retrieved on: 
Tuesday, August 3, 2021
Branches of biology, Biology, Quality, Laboratory techniques, Medicine, Cell biology, Clinical pathology, Medical tests, Validation, Cleaning validation, Flow cytometry, Cytometry

6.3.6.1 Increasing Use of Molecular Imaging, Flow Cytometry, and Immunohistochemistry to Boost Segment

Key Points: 
  • 6.3.6.1 Increasing Use of Molecular Imaging, Flow Cytometry, and Immunohistochemistry to Boost Segment
    6.4.6.1 Used to Ensure Long-Term Quality, Safety, and Efficacy of Pharmaceutical Products
    6.4.7.1 Demand for Analytical Method Validation, Cleaning Validation, and Microbial Testing to Propel Segment Growth

Global Clinical Laboratory Service Market (2020 to 2025) - by Specialty Test and Services Overview, Provider Group and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021
Health, General Health, Branches of biology, Clinical pathology, Medical laboratory, Clinical chemistry, Medical specialty, Endocrinology, Medical laboratory scientist

The "Clinical Laboratory Service Markets, 6th Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Clinical Laboratory Service Markets, 6th Edition" report has been added to ResearchAndMarkets.com's offering.
  • This report provides an overview of the clinical laboratory industry and the trends driving growth.
  • Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies.
  • Information is presented as a global focused market report, with key regions discussed including:
    Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland)
    The laboratory service market is also covered by specialty, including:
    Essential and Routine Testing (clinical chemistry, hematology, coagulation, endocrinology)

908 Devices to Report Second Quarter Financial Results on August 4, 2021

Retrieved on: 
Wednesday, July 21, 2021
Branches of biology, Chemical pathology, Clinical pathology, Mass spectrometry, Spectrometers, Handheld game console, Science and technology, Science

BOSTON, July 21, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS)a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2021 before market open on Wednesday, August 4, 2021.

Key Points: 
  • BOSTON, July 21, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS)a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2021 before market open on Wednesday, August 4, 2021.
  • Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
  • Live audio of the webcast will be available on the Investors section of the company website at: www.908devices.com .
  • 908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications.

BD Launches Reimagined Digital Marketplace for Flow Cytometry

Retrieved on: 
Wednesday, July 7, 2021
Branches of biology, Biology, Laboratory techniques, Life sciences, Cell biology, Clinical pathology, Flow cytometry, BD

The new BD Biosciences website offers a full array of BD research, clinical and single-cell multiomic products, making this online destination one of the most comprehensive for flow cytometry users.

Key Points: 
  • The new BD Biosciences website offers a full array of BD research, clinical and single-cell multiomic products, making this online destination one of the most comprehensive for flow cytometry users.
  • "We listened to our customers, both researchers and clinical lab managers, to understand and address the barriers they face to buying," said Puneet Sarin, worldwide president of BD Biosciences.
  • "Our goal is to empower them with tools and relevant scientific content to make the process of online product search and purchase faster, easier and more convenient across the complete flow cytometry continuum."
  • The completely overhauled online purchasing experience offers intuitive navigation, a fully integrated shopping experience, and a look and feel that addresses flow cytometry users' buying needs.

Global Clinical Laboratory Market Analysis Report 2021-2026 with Impacts/Changes of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 6, 2021
Biotechnology, Health, Science, Other Science, Research, Companies, Life sciences, Industry economics), Clinical pathology, Corning Inc., Medical diagnosis, Medical laboratory, Qiagen, Ortho Clinical Diagnostics, Quest Diagnostics, LabCorp, Agilent Technologies

The "Global Clinical Laboratory Market - Analysis By Test, End User, By Region, By Country (2021 Edition): Market Insights and Forecast with impact of COVID-19 (2021-2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Clinical Laboratory Market - Analysis By Test, End User, By Region, By Country (2021 Edition): Market Insights and Forecast with impact of COVID-19 (2021-2026)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Clinical Laboratory Market is estimated at USD 23.9 billion in the year 2020.
  • The report analyses the Clinical Laboratories Market by End User (Hospital Based Laboratories, Clinical Based Laboratories, Independent Laboratories, Reference Laboratories, Others).
  • The companies analysed in the report include Abbott Laboratories, Ortho Clinical Diagnostics, Charles River Laboratories Inc., SGS S.A., QIAGEN, OPKO Health Inc., Sartorius Ag, Laboratory Corporation of America Holding, Quest Diagnostics, Eurofins Scientific
    4 Global Clinical Laboratory Market: Sizing and Forecast
    4 1 Global Clinical Laboratory Market Size, By Value, Year 2016-2026
    5 Global Clinical Laboratory Market Segmentation - By Test, By End User
    5 1 Competitive Scenario of Global Clinical Laboratory Market: By Test
    5 2 Competitive Scenario of Global Clinical Laboratory Market: By End user
    6 Global Clinical Laboratory Market: Regional Analysis
    7 North America Clinical Laboratory Market: An Analysis (2016-2026)
    8 Europe Clinical Laboratory Market: An Analysis (2016-2026)
    9 Asia Pacific Clinical Laboratory Market: An Analysis (2016-2026)
    10 LAMEA Clinical Laboratory Market: An Analysis (2016-2026)